Longevity peptide protocols — NAD+, epitalon, MOTS-c, thymalin. Dose ranges, cycle structure, reconstitution, and the mitochondrial research behind them.
Longevity peptides target cellular and mitochondrial pathways rather than a single tissue. NAD+ supports mitochondrial energy metabolism, epitalon is studied for telomerase activity, and MOTS-c is a mitochondrial-derived peptide studied for metabolic regulation. Most are run in short pulsed cycles rather than continuously.
Category overview
Reverse cellular decline, enhance vitality, and extend healthspan. These peptides target fundamental aging mechanisms: telomeres, mitochondria, immune function, and cellular repair.
Protocols at a glance
Peptide
Dose range
Frequency
Cycle
Epitalon
5 – 20 mg
Daily (PM)
10–20 days on, 4–6 months off (unique cycling pattern)
Thymosin Alpha-1
1.6 – 3.2 mg
2–3×/week to daily
4–8 weeks on, 2–4 weeks off; seasonal use pre-flu season
Humanin
0.5 – 4 mg
Daily
8–12 weeks on, 4 weeks off
SS-31 / Elamipretide
10 – 80 mg
Daily
8–12 weeks on, 4 weeks off
Glutathione
200 – 600 mg
2–3×/week (IV/IM) or daily (SubQ low-dose)
8–12 weeks on, 2–4 weeks off
Epitalon — Epithalon / Epithalamin
Synthetic tetrapeptide that activates telomerase to maintain telomere length. Developed by Russian scientist Vladimir Khavinson; one of the most researched longevity peptides.
Dose range: 5 – 20 mg. Frequency: Daily (PM). Cycle: 10–20 days on, 4–6 months off (unique cycling pattern).
Reconstitution: 2mg → 1ml bacteriostatic water
Reconstitution: 5mg → 2ml bacteriostatic water
Reconstitution: 10mg → 2ml bacteriostatic water
Activates telomerase enzyme to elongate telomeres
Regulates pineal gland for improved melatonin/sleep
FDA-approved in some countries for immune support. Produced naturally by the thymus gland; levels decline with age. Key for maintaining immune competence as we age.
Dose range: 1.6 – 3.2 mg. Frequency: 2–3×/week to daily. Cycle: 4–8 weeks on, 2–4 weeks off; seasonal use pre-flu season.
Reconstitution: 2mg → 1ml bacteriostatic water
Reconstitution: 5mg → 2ml bacteriostatic water
Reconstitution: 10mg → 2ml bacteriostatic water
Boosts T-cell function for enhanced infection resistance
Mitochondrial-targeted peptide that concentrates in cardiolipin-rich inner mitochondrial membrane. In clinical trials for heart failure and mitochondrial diseases.
Still in clinical development; follow trial protocols.
Stacks: MOTS-c, Humanin, CoQ10 + PQQ
Glutathione — GSH / L-Glutathione
The principal endogenous antioxidant — a tripeptide of glutamate, cysteine, and glycine. Central to detoxification, redox balance, and immune function; cellular levels decline with age and oxidative stress.
Dose range: 200 – 600 mg. Frequency: 2–3×/week (IV/IM) or daily (SubQ low-dose). Cycle: 8–12 weeks on, 2–4 weeks off.
Reconstitution: 2mg → 1ml bacteriostatic water
Reconstitution: 5mg → 2ml bacteriostatic water
Reconstitution: 10mg → 2ml bacteriostatic water
Neutralizes reactive oxygen species and regenerates other antioxidants
Supports Phase II liver detoxification pathways
Modulates immune cell function and inflammation
Skin brightening and even-tone effects reported in clinical use
Often paired with NAD+ and Vitamin C for redox support.
Light- and oxygen-sensitive — keep reconstituted vials refrigerated and shielded.
Start Low, Go Slow: Always begin with the minimum effective dose and titrate gradually over weeks.
Get Baseline Bloodwork: Before starting, obtain labs including CBC, CMP, lipid panel, hormone panel (testosterone, estrogen, IGF-1, GH), fasting insulin, HbA1c, liver enzymes, and inflammatory markers.
Monitor Regularly: Retest labs every 4–8 weeks. Track subjective markers daily (sleep, energy, mood, appetite, injection site reactions).
Source Responsibly: Only use peptides from reputable compounding vendors with third-party COA testing. We STRONGLY recommend they also are based out of the USA for quality assurance.
Recognize Warning Signs: Stop immediately and seek medical attention for severe injection site reactions, difficulty breathing, chest pain, severe headache, vision changes, or allergic reactions.
Drug Interactions: Many peptides interact with insulin, diabetes drugs, blood thinners, immunosuppressants, and hormonal therapies.
Contraindications: Not for pregnant/breastfeeding women, individuals under 18, those with active cancer, severe liver/kidney disease, or uncontrolled diabetes.
Important
All peptide products referenced are intended solely for research, investigational, or licensed professional use. They are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed medical practitioner before any personal or clinical use.